Medicinal Research Reviews

SJR Rank #635H-index: 167SJR: 3.265Best quartile: Q1APC: US$4,980
Journal website: aims, scope and author guidelines
Publisher

John Wiley & Sons Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.851.72.553.4

Subject Categories

  • Drug DiscoveryQ1
  • Molecular MedicineQ1
  • PharmacologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Computational Drug Discovery MethodsReceptor Mechanisms and SignalingChemical Synthesis and AnalysisHIV/AIDS drug development and treatmentCancer therapeutics and mechanismsMonoclonal and Polyclonal Antibodies ResearchClick Chemistry and ApplicationsProtein Degradation and InhibitorsNeuropeptides and Animal PhysiologyNeuroscience and Neuropharmacology Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs050100150200

Documents per Year

20222025020406080

Detailed Information

ISSN

0198-6325, 1098-1128

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

14.76

References per Document

204.77

Coverage

1981-2026

Scope

Medicinal Research Reviews publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Articles are mainly solicited by the Editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline (see below) before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

Metrics from SCImago Journal Rank 2025. View on SCImago